Skip to main content

Advertisement

Log in

Recreational Use of HIV Antiretroviral Medication and Implications for HIV Pre-exposure Prophylaxis and Treatment

  • Original Paper
  • Published:
AIDS and Behavior Aims and scope Submit manuscript

Abstract

Diversion of antiretroviral therapy (ART) for recreational use is concerning for countries with high HIV prevalence. This paper presents reports of recreational use of ART among adolescents from two HIV prevention studies in South Africa: (1) a cross-sectional survey of N = 200 adolescents and (2) a qualitative study of pre-exposure prophylaxis with N = 57 adolescents and N = 25 clinicians. Among adolescents, 3% used and 14% knew someone who used non-prescribed ART for recreational purposes. Administration included smoking (71%), snorting (15%), injecting (15%), ingesting (15%), and inserting (3%). Participants predicted increased crime as recreational use of ART increased. Future studies should investigate prevalence, composition, and diversion of ART from HIV prevention and treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Shisana O, Rehle T, Zuma K, Jooste SNZ, et al. South African national HIV prevalence, incidence and behaviour survey, 2017. Cape Town: HSRC Press; 2018.

    Google Scholar 

  2. Haire B, Kaldor JM. Ethics of ARV based prevention: treatment-as-prevention and PrEP. Dev World Bioethics. 2013;13(2):63–9.

    Google Scholar 

  3. Surratt HL, Kurtz SP, Cicero TJ, O'Grady C, Levi-Minzi MA. Antiretroviral medication diversion among HIV-positive substance abusers in South Florida. Am J Public Health. 2013;103(6):1026–8.

    PubMed  PubMed Central  Google Scholar 

  4. Buttram ME, Kurtz SP. Preliminary evidence of HIV seroconversion among HIV-negative men who have sex with men taking non-prescribed antiretroviral medication for HIV prevention in Miami, Florida, USA. Sex Health. 2017;14(2):193–5.

    PubMed  Google Scholar 

  5. Grelotti DJ, Closson EF, Mimiaga MJ. Pretreatment antiretroviral exposure from recreational use. Lancet Infect Dis. 2013;13(1):10–2.

    PubMed  PubMed Central  Google Scholar 

  6. Larkan F, Van Wyk B, Saris AJ. Of remedies and poisons: recreational use of antiretroviral drugs in the social imagination of South African Carers. Afri Sociol Rev. 2010;14(2):62–73.

    Google Scholar 

  7. Davis GP, Surratt HL, Levin FR, Blanco C. Antiretroviral medication: an emerging category of prescription drug misuse. Am J Addict. 2014;23(6):519–25.

    PubMed  Google Scholar 

  8. Lekgetho M. Teens' ARV abuse shocks parents. Health e-News. 2019;10:2019.

    Google Scholar 

  9. Kurtz SP, Buttram ME, Surratt HL. Vulnerable infected populations and street markets for ARVs: potential implications for PrEP rollout in the USA. AIDS Care. 2014;26(4):411–5.

    PubMed  Google Scholar 

  10. Grelotti DJ, Closson EF, Smit JA, Mabude Z, Matthews LT, Safren SA, et al. Whoonga: potential recreational use of HIV antiretroviral medication in South Africa. AIDS Behav. 2014;18(3):511–8.

    PubMed  PubMed Central  Google Scholar 

  11. Rough K, Dietrich J, Essien T, Grelotti DJ, Bansberg DR, Gray G, et al. Whoonga and the abuse and diversion of antiretrovirals in Soweto. South Africa AIDS Behav. 2014;18(7):1378–80.

    PubMed  Google Scholar 

  12. Tsuyuki K, Surratt HL, Levi-Minzi MA, O'Grady CL, Kurtz SP. The Demand for antiretroviral drugs in the illicit marketplace: implications for HIV disease management among vulnerable populations. AIDS Behav. 2015;19(5):857–68.

    PubMed  PubMed Central  Google Scholar 

  13. Inciardi JA, Surratt HL, Kurtz SP, Cicero TJ. Mechanisms of prescription drug diversion among drug-involved club- and street-based populations. Pain Med. 2007;8(2):171–83.

    PubMed  PubMed Central  Google Scholar 

  14. Kuo C, Atujuna M, Mathews C, Stein DJ, Hoare J, Beardslee W, et al. Developing family interventions for adolescent HIV prevention in South Africa. AIDS Care. 2016;28(Suppl 1):106–10.

    PubMed  PubMed Central  Google Scholar 

  15. Giovenco D, Kuo C, Underhill K, Hoare J, Operario D. “The time has arrived”: Perceptions of behavioral adjustments in the context of pre-exposure prophylaxis availability among adolescents in South Africa. AIDS Educ Prev. 2018;30(6):463–73.

    PubMed  PubMed Central  Google Scholar 

  16. NVivo qualitative data analysis software. Version 10 ed: QSR International Pty Ltd; 2012.

  17. Strauss A, Corbin J. Basics of qualitative research: grounded theory procedures and techniques. London: Sage Publications; 1990.

    Google Scholar 

  18. Dalwadi DA, Ozuna L, Harvey BH, Viljoen M, Schetz JA. Adverse neuropsychiatric events and recreational use of Efavirenz and other HIV-1 antiretroviral drugs. Pharmacol Rev. 2018;70(3):684–711.

    CAS  PubMed  Google Scholar 

  19. Brian Gazzard AB. A Hill, Analysis of neuropsychiatric adverse events during clinical trials of Efavirenz in antiretroviral-naive patients: a systematic review. AIDS Rev. 2010;12(2):67–75.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Caroline Kuo.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kuo, C., Giovenco, D., DeAtley, T. et al. Recreational Use of HIV Antiretroviral Medication and Implications for HIV Pre-exposure Prophylaxis and Treatment. AIDS Behav 24, 2650–2655 (2020). https://doi.org/10.1007/s10461-020-02821-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10461-020-02821-5

Keywords

Navigation